TDF partners help us customize and execute each project to its fullest. We partner with various organizations and resources to help shape and advance our projects to their desired endpoints.
TIDO invites inquiries for partnerships and collaborations. Interested parties can contact Khadija Elabid, Program Coordinator, Technology Development Fund at technology.development@childrens.harvard.edu.
Technology Development Fund Advisory Board
| Advisory Board Member | Title and Organization |
| Joe Bolen, PhD | Chief Scientific Officer at PureTech Health |
| Jerry Casey, MBA | Independent Consultant Former President and COO, Sekisui Diagnostics, LLC |
| Margaret Chu-Moyer, PhD | Executive Director of Research, and Massachusetts Site Head, Amgen |
| Anthony J. Coyle, PhD | CEO at Pandion Therapeutics |
| Alan Crane, MBA | Venture Partner and Entrepreneur, Polaris Venture Partners |
| Skip Fleshman, MS | Partner, Asset Management Ventures |
| Sandra Glucksman, PhD | Entrepreneur In Residence at Third Rock Ventures |
| Keith Gottesdiener, MD | CEO, Rhythm Pharmaceuticals, Inc. |
| Michael Magliochetti, MBA, PhD | Operating Partner, Riverside Partners |
| Patrice Milos, PhD | President, CEO and Founder, Medley Genomics |
| Imran Nasrullah, MS, JD, CLP | Director, Innovation Sourcing, Boehringer Ingelheim |
| Simon Read, PhD | Chief Scientific Officer, Ra Pharma |
| Ken Rhodes, PhD | Chief Scientific Officer, Yumanity Therapeutics |
| Craig Sorensen, PhD
|
Independent Pharma Consultant Former Vice President, External Research and Innovation, Vertex Pharmaceuticals Inc. |
| Beverly Teicher, PhD | Chief, Molecular Pharmacology Branch, National Cancer Institute |
| Josh Tolkoff, MS Eng | Managing Director, Ironwood Capital Management; Accelerator Executive, CIMIT |
| Stacie Weninger, PhD | Executive Director, F-Prime Biomedical Research Initiative |
Technology Development Fund Industry Partners
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |